« Previous
Next »
American Journal of Cardiology
Volume 102, Issue 6
, Pages 738-742
, 15 September 2008
Stage-Related Effect of Statin Treatment on the Progression of Aortic Valve Sclerosis and Stenosis
References
- . Clinical factors associated with calcific aortic valve disease: Cardiovascular Health Study. J Am Coll Cardiol. 1997;29:630–634
- ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol. 2006;48:e1–e148
- . Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Am J Cardiol. 2001;88:693–695
- . Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community. J Am Coll Cardiol. 2002;40:1723–1730
- . Effect of hydroxymethylglutaryl coenzyme A reductase inhibitors on the progression of calcific aortic stenosis. Circulation. 2001;104:2205–2209
- . Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis. Circulation. 2004;110:1291–1295
- . Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol. 2007;49:554–561
- . A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med. 2005;352:2389–2397
- . Why is aortic sclerosis associated with adverse clinical outcomes?. J Am Coll Cardiol. 2004;43:176–178
- . The risk of development of aortic stenosis in patients with “benign” aortic valve thickening. Arch Intern Med. 2002;162:2345–2347
- . Appropriateness criteria for transthoracic and transesophageal echocardiography. J Am Coll Cardiol. 2007;50:187–204
- . Progression of aortic valve sclerosis and aortic valve stenosis: what is the role of statin treatment?. Ital Heart J. 2005;6:119–124
- ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am SocEchocardiogr. 2003;16:1091–1110
- . Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307–310
- Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study. Am J Cardiol. 2007;99:970–973
- . Rationale, design, and baseline characteristics of a randomized trial to assess the effect of cholesterol lowering on the progression of aortic stenosis: The Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) trial. Am Heart J. 2007;153:925–931
- . Statin therapy of calcific aortic stenosis: hype or hope?. Eur Heart J. 2006;27:773–778
- . Statins in aortic stenosis. J Am Coll Cardiol. 2007;49:562–564
- . Insights into degenerative aortic valve disease. J Am Coll Cardiol. 2007;50:1205–1213
- . Why is there discordance between calcific aortic stenosis and coronary artery disease?. Heart. 2001;85:601–602
- . Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 1999;341:142–147
Drs. Monica Hîrşu and Bogdan A. Popescu were supported by research grants from the Association for Research in Cardiology, Pordenone, Italy.
PII: S0002-9149(08)00847-3
doi: 10.1016/j.amjcard.2008.04.056
© 2008 Elsevier Inc. All rights reserved.
« Previous
Next »
American Journal of Cardiology
Volume 102, Issue 6
, Pages 738-742
, 15 September 2008
